Evaluation of the Rapidec Carba NP Test for Detection of Carbapenemases in Enterobacteriaceae

ABSTRACT This study evaluated the performance of the Rapidec Carba NP test, which was introduced recently into the market for the detection of carbapenemase production in a broad spectrum of β-lactamase-producing Enterobacteriaceae clinical isolates. In total, 252 clinical Enterobacteriaceae isolates that had been genetically characterized with respect to carbapenemase, extended-spectrum β-lactamase (ESBL), and AmpC genes were analyzed; 51/252 isolates (20.2%) were genetically confirmed to be carbapenemase producers, whereas 201/252 isolates (79.8%) were genetically negative for the presence of carbapenemase genes. The Rapidec Carba NP test was applied according to the manufacturer's instructions, and results were read after 30 and 120 min of incubation. The overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Rapidec Carba NP test were 90.2%, 100%, 100%, and 97.6%, respectively, when the manufacturer's instructions were followed. Four of 5 false-negative results occurred with OXA-48-like enzymes. After an incubation time of 30 min, the sensitivity was 49%. The sensitivity increased to 100% when the recommended bacterial inoculum was doubled and the test was read strictly after 120 min of incubation. The Rapidec Carba NP test is a useful tool for the reliable confirmation of carbapenemase-producing Enterobacteriaceae isolates. The test should be read strictly after 120 min of incubation and the inoculum should be larger than recommended by the manufacturer.

[1]  R. Bonomo,et al.  Performance of the CLSI Carba NP and the Rosco Carb Screen Assays Using North American Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa Isolates , 2015, Journal of Clinical Microbiology.

[2]  P. Nordmann,et al.  Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers , 2015, Journal of Clinical Microbiology.

[3]  Florian P Maurer,et al.  Evaluation of Carbapenemase Screening and Confirmation Tests with Enterobacteriaceae and Development of a Practical Diagnostic Algorithm , 2014, Journal of Clinical Microbiology.

[4]  P. Nordmann,et al.  Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. , 2014, The Journal of antimicrobial chemotherapy.

[5]  G. Bloemberg,et al.  Evaluation of the AID ESBL line probe assay for rapid detection of extended-spectrum β-lactamase (ESBL) and KPC carbapenemase genes in Enterobacteriaceae. , 2014, The Journal of antimicrobial chemotherapy.

[6]  J. Kop,et al.  Detection of Colonization by Carbapenemase-Producing Gram-Negative Bacilli in Patients by Use of the Xpert MDRO Assay , 2013, Journal of Clinical Microbiology.

[7]  Hui Wang,et al.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. , 2013, The Lancet. Infectious diseases.

[8]  Robin Patel,et al.  Comparison of a Novel, Rapid Chromogenic Biochemical Assay, the Carba NP Test, with the Modified Hodge Test for Detection of Carbapenemase-Producing Gram-Negative Bacilli , 2013, Journal of Clinical Microbiology.

[9]  Samir N. Patel,et al.  Evaluation of the Carba NP Test for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.

[10]  Paige E. Waterman,et al.  Rapid and Simultaneous Detection of bla KPC and bla NDM by Use of Multiplex Real-Time PCR , 2013, Journal of Clinical Microbiology.

[11]  K. Bush,et al.  The ABCD’s of β-lactamase nomenclature , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[12]  G. Bloemberg,et al.  Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  P. Nordmann,et al.  Rapid Identification of Carbapenemase Types in Enterobacteriaceae and Pseudomonas spp. by Using a Biochemical Test , 2012, Antimicrobial Agents and Chemotherapy.

[14]  P. Nordmann,et al.  Rapid Detection of Carbapenemase-producing Enterobacteriaceae , 2012, Emerging infectious diseases.

[15]  P. Nordmann,et al.  Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). , 2012, The Journal of antimicrobial chemotherapy.

[16]  P. Nordmann,et al.  OXA-48-like carbapenemases: the phantom menace. , 2012, The Journal of antimicrobial chemotherapy.

[17]  V. Miriagou,et al.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  Rafael Cantón,et al.  EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance , 2012 .

[19]  K. Bush,et al.  Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. , 2011, Annual review of microbiology.

[20]  R. Zbinden,et al.  Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis , 2011, Journal of Clinical Microbiology.

[21]  G. Bloemberg,et al.  Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing Enterobacteriaceae , 2011, Journal of Clinical Microbiology.

[22]  P. Nordmann,et al.  Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.

[23]  N. Woodford,et al.  A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  Samir N. Patel,et al.  Comparative Evaluation of a Chromogenic Agar Medium, the Modified Hodge Test, and a Battery of Meropenem-Inhibitor Discs for Detection of Carbapenemase Activity in Enterobacteriaceae , 2011, Journal of Clinical Microbiology.

[25]  S. Pournaras,et al.  A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. , 2010, The Journal of antimicrobial chemotherapy.

[26]  A. Corso,et al.  Sensitive Screening Tests for Suspected Class A Carbapenemase Production in Species of Enterobacteriaceae , 2009, Journal of Clinical Microbiology.

[27]  N. Woodford,et al.  Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. , 2009, The Journal of antimicrobial chemotherapy.

[28]  M. Falagas,et al.  Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. , 2008, The Journal of antimicrobial chemotherapy.

[29]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[30]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[31]  R. Ambler,et al.  The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.